Primary tabs
The list of publications is indicative and may not include all publications.
Racial, ethnic and sex disparities among participants in cardiovascular outcomes trials in type 2 diabetes: A systematic review and descriptive analysis..
Diabetes Obes Metab. 25(2), 618-622.
(2023).
Management of type 2 diabetes in the new era..
Hormones (Athens). 22(4), 677-684.
(2023).
Burden and Coping Strategies of Hypoglycemia in People with Diabetes..
Curr Diabetes Rev.
(2023).
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis..
Diabetes Obes Metab. 25(10), 3020-3029.
(2023).
Socioeconomic aspects of incretin-based therapy..
Diabetologia. 66(10), 1859-1868.
(2023).
A Simple Guide to Systematic Reviews and Meta-Analyses..
Int J Low Extrem Wounds. 15347346231169842.
(2023).
Diagnostic Accuracy of CMR With Late Gadolinium Enhancement for Ischemic Cardiomyopathy: A Systematic Review and Meta-Analysis..
JACC Cardiovasc Imaging. 16(3), 399-401.
(2023).
Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece..
Hemoglobin. 46(2), 143-145.
(2022).
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis..
Diabetologia. 65(8), 1251-1261.
(2022).
Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events..
Clin Nutr. 41(4), 923-930.
(2022).
Reporting completeness in abstracts of systematic reviews of diagnostic test accuracy studies in cardiovascular diseases is suboptimal..
Hellenic J Cardiol. 25-34.
(2022).
The relationship between early symptom severity, improvement and remission in first episode psychosis with jumping to conclusions..
Schizophr Res. 240, 24-30.
(2022).
Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 24(1), 106-114.
(2022).
Non-dipping pattern in early-stage diabetes: association with glycemic profile and hemodynamic parameters..
J Hum Hypertens. 36(9), 805-810.
(2022).
Efficacy and safety of ultra-rapid insulin analogues in insulin pumps in patients with Type 1 Diabetes Mellitus: A systematic review and meta-analysis..
Diabetes Res Clin Pract. 193, 110144.
(2022).
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes..
Ann Intern Med. 174(1), 141.
(2021).
Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis..
Diabetes Obes Metab. 23(3), 822-831.
(2021).
Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus..
Am J Hypertens. 34(4), 404-413.
(2021).